A Japanese multi-institutional phase II study of moderate hypofractionated intensity-modulated radiotherapy with image-guided technique for prostate cancer.
Nakamura K, Nihei K, Saito Y, Shikama N, Noda SE, Hara R, Imagumbai T, Mizowaki T, Akiba T, Kunieda E, Someya M, Ohga S, Kawamori J, Kozuka T, Ota Y, Inaba K, Kodaira T, Itoh Y, Funakoshi K, Kagami Y.
Nakamura K, et al. Among authors: mizowaki t.
Int J Clin Oncol. 2024 Jun;29(6):847-852. doi: 10.1007/s10147-024-02517-z. Epub 2024 Apr 17.
Int J Clin Oncol. 2024.
PMID: 38630382
Clinical Trial.